why choose us

First received: December 22, 2023

Clinical Trial: Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: Thalassemia

Study Type: OBSERVATIONAL


Official Title: Evaluating the Prescribing Pattern and Knowledge, Attitude and Practice as Well as the Adherence Level to Iron Chelation Therapy in Thalassemia

Brief Summary: Thalassemias are a heterogeneous grouping of genetic disorders that result in dysfunctional Hb, reduced RBC life span leading to chronic anemia .Thalassemia is endemic in the Middle East.Iron chelation therapy (ICT) is one of treatment used however ICT is associated with patients adherence problem thus impacting its effectiveness .

Read more